Clinical Studies
Developing new treatments is important for continually improving patient care. Please click on the following links to learn more about KalVista's KONFIDENT clinical trial:
KVD900-301 (KONFIDENT Study) is a Phase 3 clinical trial to evaluate sebetralstat for the on-demand treatment of hereditary angioedema (HAE) attacks.
Find a Participating Site:
|
|
|
|
|
|
|
|
|
|
|
|
|
(english) |
(español) |